Table 2.

Clinical data of patients.

	Age(years)	Sex	24hTP (g)	Hb (g/L)	HbA1C (%)	Scr (μmol/L)	Alb (g/L)	eGFR (ml/min/1.73 m2)
Patient 1*	38	Male	1.03	153	8.4	69	48.7	114.475
Patient 2*	45	Female	4.19	80	6.3	91	29.4	68.578
Patient 3*	53	Female	2.81	127	7.3	126	39.8	55.734
Patient 4	40	Male	0.83	151	6.7	66	45	114.959
Patient 5	46	Male	10.12	110	5.6	167	23.5	41.645
Patient 6	55	Male	7.31	98	8.3	202	30.1	31.060
Patient 7	46	Male	2.7	132	7.1	59	40.7	115.412
Patient 8	54	Female	3.51	94	8.2	85	28.1	67.133
Patient 9	49	Female	6.34	86	5.5	435	27.5	9.659
Control 1*	48	Male	0.14	122	5.1	101	38.8	70.306
Control 2*	53	Female	0.06	127	4.6	77	42.5	97.110
Control 3*	45	Male	0.11	146	5.9	70	42.3	107.581
Control 4	59	Male	0.16	162	4.7	84	46.3	87.239
Control 5	62	Male	0.04	135	4.2	63	34.7	120.951
Control 6	58	Female	0.18	118	5.3	58	35.6	97.875
Control 7	66	Male	0.12	137	5.7	76	39.7	93.736
Control 8	68	Female	0.19	108	5.1	69	32.4	78.294
Control 9	57	Female	0.03	119	4.5	70	40.2	83.125

*The kidney tissues of these three pairs of patients were subjected to circRNA high-throughput sequencing.

24hTP, 24h urine total protein; Hb, hemoglobin; HbA1C, glycosylated hemoglobin; Scr, serum creatinine; Alb, serum albumin; eGFR, estimated glomerular filtration rate.